By InvitationNot Applicable

Sahlgrenska Cardiomyopathy Project

Sweden3,000 participantsStarted 2018-06-01

Plain-language summary

This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal. Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP) including in depth clinical and molecular phenotyping to enable earlier and specific treatment. The project will serve as: 1. resource for diagnostic and therapeutic trials 2. common biomaterial bank 3. resource for detailed molecular analyses on patients' biomaterials and patient specific symptoms and examination results

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with primary cardiomyopathies including hereditary and inflammatory dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, left ventricular non-compaction cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, giant cell myocarditis, sarcoidosis and amyloidosis engaging the heart Exclusion Criteria: * Patient with other preexisting cardiac diseases such as significant valvular, ischemic or pericardial disease before they receive a cardiomyopathy diagnose * patients \< 18 years

What they're measuring

Time to disease progression

Timeframe: 2018-2028

Trial details

NCT IDNCT03527342

SponsorGöteborg University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-01

View on ClinicalTrials.gov More Dilated Cardiomyopathies trials